Study Of Circulating Levels Of Mir-126 And Vascular Complication In End Stage Renal Disease Patients On Heamodialysis

Document Type : Original Article

Authors

1 Internal medicine department, Faculty of Medicine, Beni-Suef University, Egypt

2 Radiology department, Faculty of Medicine, Beni-Suef University, Egypt

Abstract

Vascular calcification is a major complication of End stage renal disease patient on hemodialysis. A cross sectional cohort study in Beni Suef university hospital for a group of patients with End stage renal disease on regular hemodialysis. In total, 70 participants were divided into the study (50 patients) and (20 control groups). group showed higher miR-126 levels compared with the  control  group.  Carotid  intimal  medial  thickness  (CIMT)  was  positively  correlated  with  miR- 126.

Keywords

Main Subjects

References

  1. Amabile     N,     Guerin     AP,     Tedgui     A, Boulanger  CM,  London  GM.  Predictive value       of       circulating       endothelial microparticles        for        cardiovascular mortality  in  end-stage  renal  failure:  a pilot                study. Nephrol                Dial Transplant. 2012; 27:1873–1880.
  2. Braun    J,    Oldendorf    M,    Moshage    W, Heidler  R,  Zeitler  E,  Luft  FC:  Electron beam   computed   tomography   in   the evaluation   of   cardiac   calcification   in chronic   dialysis   patients. Am   J   Kidney Dis 27 : 394 –401, 1996
  3. Coresh    J,    Astor    BC,    Graene    T,    et al. Prevalence of chronic kidney disease and  decreased  kidney  function  in  the adult   US   population.   Third   National Health     and     Nutrition     Examination Survey. Am J Kidney Dis 2003;41:1-12.
  4. Fish  JE,  Santoro  MM,  Morton  SU,  Yu  S, Yeh  RF,  Wythe  JD,  et  al.  parathyroid hormone    level    regulates    angiogenic signaling    and    vascular    integrity. Dev Cell. 2008; 15:272–284.
  5. Salusky IB: Coronary-artery calcification in young    adults    with    end-stage    renal disease  who  are  undergoing  dialysis. N Engl J Med 342 : 1478 –1483, 2000
  6. .Levin      A.     Clinical     epidemiology     of cardiovascular disease in chronic kidney disease       prior       to       dialysis. Semin Dial. 2003; 16:101–105.
  7. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al.        Circulating    microRNAs    as    stable blood-based      markers      for      cancer detection. Proc    Natl    Acad    Sci    U    S A. 2008; 105:10513–10518
  8. Mitterbauer  C,  Schwarz  C,  and  Haas  M, Oberbauer R: Effects of bisphosphonates on bone loss in the first year after renal transplantation:    A    meta-analysis    of randomized    controlled    trials. Nephrol Dial Transplant 21 : 2275 –2281, 2006
  9. Moe SM, O’Neill KD, Duan D, Ahmed S, Chen   NX,   Leapman   SB,   Fineberg   N, Kopecky  K:  Medial  artery  calcification in   ESRD   patients   is   associated   with deposition         of         bone         matrix proteins. Kidney Int 61 : 638 –647,2002
  10. National     Kidney     Foundation. Kidney Disease. New York, NY: National Kidney Foundation:2008
  11. Naves M, Guinsburg A, Marelli C, Tejada J, Silvestri F, Passlick-Deetjen J, Cannata- Andia   J:   Relative   risk   (RR)   of   death according   to   serum   Ca,   P   and   PTH. Results  from  a  large  sample  of  dialysis patients from Latin America followed for up to 54 months. The CORES Study J Am Soc Nephrol 16 : 728A , 2005
  12. Neal  CS,  Michael  MZ,  Pimlott  LK,  Yong TY,    Li    JY,    Gleadle    JM.    Circulating microRNA   expression   is   increased   in chronic    kidney    disease. Nephrol    Dial Transplant. 2011; 26:3794–3802.
  13. Nitta  K,  Akiba  T,  Suzuki  K,  Uchida  K, Watanabe R, Majima K, Aoki T, Nihei H: Effects  of  cyclic  intermittent  etidronate therapy  on  coronary  artery  calcification in       patients       receiving       long-term hemodialysis. Am J Kidney Dis 44 : 680 – 688, 2004
  14. O’Hare  AM,  Choi  AI,  Bertenthal  D. Age affects    outcomes    in    chronic    kidney disease. J      Am      Soc      Nephrol 2007; 18:2758 2765.
  15. Price   PA,   Faus   SA,   Williamson   MK: Bisphosphonates       alendronate       and ibandronate  inhibit  artery  calcification at   doses   comparable   to   those   that inhibit      bone      resorption. Arterioscler Thromb Vasc Biol 21 : 817 –824, 2001
  16. Prokopi  M,  Pula  G,  Mayr  U,  Devue  C, Gallagher  J,  Xiao  Q,  et  al.  Proteomic analysis   reveals   presence   of   platelet microparticles  in endothelial  progenitor cell     cultures. Blood. 2009;     114:723– 732.
  17. Schafer     C,     Heiss     A,     Schwarz     A, Westenfeld   R,   Ketteler   M,   Floege   J, Muller-Esterl    W,    Schinke    T,    Jahnen- Dechent W: The serum protein alpha 2- Heremans-Schmid  glycoprotein/fetuin-A is   a   systemically   acting   inhibitor   of ectopic              calcification. J              Clin Invest 112 : 357 –366, 2003
  18. Schlondorff    DO. Overview    of    factors contributing  to  the  pathophysiology  of progressive        renal        disease. Kidney Int 2008; 74:860-866.
  19. Sequeira  Lopez  ML,  Gomez  RA.  Novel mechanisms for the control of renin synthesis and release. Curr   Hypertens Rep. 2010; 12:26–32.
  20. Xiaoying jiang , Eleni Tsitsiou ,and mark A Lindsay /microRna    and    the regulation of fibrosis 2019
  21. Zernecke   A,   Bidzhekov   K,   Noels   H, Shagdarsuren E, Gan L, Denecke B, et al. Delivery  of  microRNA-126  by  apoptotic bodies induces CXCL12-dependent vascular     protection. Sci     Signal. 2009; 2:ra81.
  22. Zhang     Q,     Kandic  I, Kutryk     MJ. Dysregulation   of   angiogenesis-related microRNAs   in   endothelial   progenitor cells from patients with coronary artery disease. Biochem Biophys Res Commun. 2011; 405:42–46.

Files

Share

How to cite

Statistics